Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Nu-Med Plus, Inc. is a global medical technology firm dedicated to the innovation, refinement, and commercialization of various medical instruments. The company's offerings include a diverse array of nitric oxide delivery systems, such as specialized units for hospital environments, clinical applications, and research settings, alongside a mobile, rechargeable device designed for portable nitric oxide gas administration. Serving a broad spectrum of healthcare entities, its primary clients consist of hospitals, integrated health systems, and the wider medical professional community. Nu-Med Plus, Inc. was founded in 2011 and maintains its corporate headquarters in Salt Lake City, Utah.
NU-Med Plus Announces Acquisition of Avid Gold and Agreement to Acquire Canadian Gold Properties
Nu-Med Plus acquired Avid Gold Ltd and entered into an agreement to purchase six gold properties from MegumaGold, spanning over 30,900 acres across Atlantic Canada.
The transaction marks a strategic diversification for the company, adding gold exploration and development to its existing medical device operations under the leadership of newly appointed Chairman William Hayde and industry veteran Fred Tejada.
Closing of the property acquisition is subject to MegumaGold shareholder approval and other customary conditions.